严重哮喘:诊断和治疗方法。关于观察

Revue francaise d'allergologie et d'immunologie clinique Pub Date : 2008-12-01 DOI:10.1016/j.allerg.2008.07.005

C. Mbuila , N. Beydon , F. Kamba , L. Mangyanda , L. Lukuni , B. Chatue , A. Personne , E. Blimpo , S. Goulhamhoussen , P. Hayat

{"title":"严重哮喘:诊断和治疗方法。关于观察","authors":"C. Mbuila , N. Beydon , F. Kamba , L. Mangyanda , L. Lukuni , B. Chatue , A. Personne , E. Blimpo , S. Goulhamhoussen , P. Hayat","doi":"10.1016/j.allerg.2008.07.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Case report</h3><p>In a 16-year-old teenager hospitalized with a severe asthma attack, the diagnosis of severe asthma associated to allergy and current tobacco smoke and allergen exposure is confirmed. Despite the use of high dose of inhaled antiasthma medication, the disease remains uncontrolled and anti-IgE, omalizumab treatment is started. After few weeks, respiratory symptoms and function dramatically improve.</p></div><div><h3>Conclusion</h3><p>Severe asthma must be readily diagnosed in order to adapt treatment and avoid fatal outcome or respiratory disability.</p></div>","PeriodicalId":92953,"journal":{"name":"Revue francaise d'allergologie et d'immunologie clinique","volume":"48 8","pages":"Pages 554-557"},"PeriodicalIF":0.0000,"publicationDate":"2008-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.allerg.2008.07.005","citationCount":"0","resultStr":"{\"title\":\"Asthme sévère : démarche diagnostique et thérapeutique. À propos d’une observation\",\"authors\":\"C. Mbuila , N. Beydon , F. Kamba , L. Mangyanda , L. Lukuni , B. Chatue , A. Personne , E. Blimpo , S. Goulhamhoussen , P. Hayat\",\"doi\":\"10.1016/j.allerg.2008.07.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Case report</h3><p>In a 16-year-old teenager hospitalized with a severe asthma attack, the diagnosis of severe asthma associated to allergy and current tobacco smoke and allergen exposure is confirmed. Despite the use of high dose of inhaled antiasthma medication, the disease remains uncontrolled and anti-IgE, omalizumab treatment is started. After few weeks, respiratory symptoms and function dramatically improve.</p></div><div><h3>Conclusion</h3><p>Severe asthma must be readily diagnosed in order to adapt treatment and avoid fatal outcome or respiratory disability.</p></div>\",\"PeriodicalId\":92953,\"journal\":{\"name\":\"Revue francaise d'allergologie et d'immunologie clinique\",\"volume\":\"48 8\",\"pages\":\"Pages 554-557\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2008-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.allerg.2008.07.005\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revue francaise d'allergologie et d'immunologie clinique\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0335745708001883\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revue francaise d'allergologie et d'immunologie clinique","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0335745708001883","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

病例报告:一名因严重哮喘发作而住院的16岁少年，确诊为与过敏和目前的烟草烟雾和过敏原暴露有关的严重哮喘。尽管使用了高剂量的吸入抗哮喘药物，但疾病仍然不受控制，并且开始了抗ige, omalizumab治疗。几周后，呼吸系统症状和功能显著改善。结论重症哮喘必须及时诊断，以适应治疗，避免致命结局或呼吸功能障碍。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

Asthme sévère : démarche diagnostique et thérapeutique. À propos d’une observation

Case report

In a 16-year-old teenager hospitalized with a severe asthma attack, the diagnosis of severe asthma associated to allergy and current tobacco smoke and allergen exposure is confirmed. Despite the use of high dose of inhaled antiasthma medication, the disease remains uncontrolled and anti-IgE, omalizumab treatment is started. After few weeks, respiratory symptoms and function dramatically improve.